Denis Dufrane, NOVADIP Biosciences - Stem Cell-Based Tissue Regeneration Therapies | LSI USA '24

Novadip is a clinical-stage company developing breakthrough stem cell-based tissue regeneration therapies to accelerate healing of large bone defects, bone non-union and spine fusion in a single treatment.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Denis Dufrane
Denis Dufrane
Novadip